BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 16
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 29
• 30

• Business

  Blueprint Medicines to Report First Quarter 2018 Financial Results on Wednesday, May 2, 2018

  Blueprint Medicines Corporation announced that it will host a live conference call and webcast at 8:30 a.m. ET on Wednesday, May 2, 2018 to report its first quarter 2018 financial results and provide a corporate update.

  April 25, 2018

   · 

  1 min read
• Business

  ImmunoGen Appoints Blaine McKee as Executive Vice President and Chief Business Officer

  ImmunoGen, Inc. is a leader in the expanding field of antibody-drug conjugates (ADCs) for the treatment of cancer

  April 25, 2018

   · 

  3 min read
• Business

  ArunA Biomedical Announces Oral Presentation of Preclinical Data at ISEV 2018

  ArunA Biomedical announced it will present data at the 2018 International Society for Extracellular Vesicles (ISEV) Annual Meeting occurring May 2-6 in Barcelona, Spain.

  April 25, 2018

   · 

  1 min read
• Drug Development

  Inclusion completed of patients with complete spinal cord injury in the first panel of BioArctic’s ongoing study

  BioArctic AB announced today that the inclusion of patients with complete spinal cord injury in the first panel has been completed in the company’s ongoing clinical Phase 1/2 study.

  April 25, 2018

   · 

  3 min read
• Policy

  Juniper Pharmaceuticals Licenses Intravaginal Ring (IVR) Platform to Daré Bioscience

  Juniper Pharmaceuticals, Inc. announced an exclusive worldwide license agreement with Daré Bioscience for the development and commercialization of the Company’s intravaginal ring (IVR) technology platform.

  April 25, 2018

   · 

  4 min read
• Business

  Genomic Health to Announce First Quarter 2018 Financial Results and Host Conference Call on Wednesday, May 2, 2018

  Genomic Health, Inc. announced that the company will host a conference call and webcast on Wednesday, May 2 at 4:30 p.m. Eastern Time to discuss its first quarter 2018 financial results.

  April 25, 2018

   · 

  2 min read
• Business

  Henry Schein To Present At Four Investor Conferences In May

  Henry Schein, Inc. announced today that the Company will present at four investor conferences in May:

  April 25, 2018

   · 

  2 min read
• Business

  Entasis Therapeutics and Zai Lab Announce Exclusive License Agreement in Asia-Pacific and Global Strategic Development Collaboration for ETX2514

  Entasis Therapeutics Holdings Inc. announced an exclusive license agreement for ETX2514 in the Asia-Pacific region and a global strategic development collaboration.

  April 25, 2018

   · 

  10 min read
• Siemens Healthineers, Hermes Pardini Group to Create an Unprecedented Automated Lab Featuring the Atellica Solution

  Siemens Healthineers has taken another leap in its efforts to transform care delivery in in-vitro diagnostics by developing “The Enterprise Project” with the Hermes Pardini Group of Minas Gerais, Brazil.

  April 25, 2018

   · 

  4 min read
• Business

  Gossamer Bio Announces Appointment of Bryan Giraudo as Chief Financial Officer

  Mr. Giraudo will lead the company’s finance and administrative functions.

  April 25, 2018

   · 

  1 min read